Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
8.19
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Bausch Health Companies Employees
Bausch Health Companies had 20,270 employees as of December 31, 2023. The number of employees increased by 370 or 1.86% compared to the previous year.
Employees
20,270
Change (1Y)
370
Growth (1Y)
1.86%
Revenue / Employee
$467,390
Profits / Employee
-$8,781
Market Cap
3.01B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Acadia Healthcare Company | 23,500 |
Neogen | 2,917 |
Inari Medical | 1,300 |
PTC Therapeutics | 1,055 |
Apellis Pharmaceuticals | 706 |
Denali Therapeutics | 445 |
Agios Pharmaceuticals | 386 |
BHC News
- 2 days ago - US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug - Reuters
- 3 days ago - PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS - Accesswire
- 3 days ago - Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis - Accesswire
- 7 days ago - Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs - Business Wire
- 21 days ago - Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Bausch Health Announces Third Quarter 2024 Results - Accesswire
- 22 days ago - Bausch + Lomb Announces Third-Quarter 2024 Results - Business Wire
- 24 days ago - ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence - Accesswire